The Men on the Move Study

NCT ID: NCT02527655

Last Updated: 2018-09-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

58 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-08-31

Study Completion Date

2016-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The Men on the Move Study is a randomized, controlled, feasibility study designed to address the health problem of physical inactivity in older men.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Men on the Move is a randomized, controlled, feasibility study to provide preliminary evidence of feasibility and efficacy for promoting mobility through the uptake of physical activity among men aged 65 years and older who are physically inactive. Specifically, Men on the Move will evaluate the effects of a choice-based physical activity model paired with an active transportation model. The choice-based physical activity model encourages older men to use existing community-based resources to create and implement actions plans for physical activity. It also provides ongoing face-to-face and telephone-based support from trained activity coaches. The active transportation model provides transit passes and active travel planning to promote use of transit and walking to destinations of interest. The feasibility of delivering the intervention will be assessed. Accelerometry and travel diaries will be used to measure the effects of the intervention on physical activity.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Physical Inactivity Mobility Limitation Older Men

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Choice-Based Physical Activity and Active Transportation

Participants will meet one-on-one with an activity coach to develop a choice-based physical activity and active transportation plan based on their interest, abilities, and resources; attend group-based motivational meetings; and receive ongoing support and encouragement for physical activity and active transportation (e.g., telephone-assisted support, community centre and transit passes).

Group Type EXPERIMENTAL

Choice-Based Physical Activity and Active Transportation

Intervention Type BEHAVIORAL

Wait-List Control

Participants will be offered the Choice-Based Physical Activity and Active Transportation intervention after the experimental arm has completed the study.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Choice-Based Physical Activity and Active Transportation

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. 65 years of age and older;
2. identify as a man;
3. English speaking; and
4. demonstrate readiness for physical activity (by the PAR-Q+ questionnaire or a letter of recommendation from their physician)

Exclusion Criteria

1. participated in any strength training in the past 3 months;
2. participated in any aerobic exercise class in the past 3 months;
3. live in a nursing home or assisted living facility; or
4. have plans to be out of town for more than 7 days during the 12-week intervention period.
Minimum Eligible Age

65 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

Sponsor Role collaborator

Centre for Hip Health and Mobility

UNKNOWN

Sponsor Role collaborator

Simon Fraser University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dawn C. Mackey

Assistant Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Dawn C Mackey, PhD

Role: PRINCIPAL_INVESTIGATOR

Simon Fraser University

Heather A McKay, PhD

Role: PRINCIPAL_INVESTIGATOR

University of British Columbia

Meghan Winters, PhD

Role: PRINCIPAL_INVESTIGATOR

Simon Fraser University

Joanie Sims-Gould, PhD

Role: PRINCIPAL_INVESTIGATOR

University of British Columbia

Christiane Hoppmann, PhD

Role: PRINCIPAL_INVESTIGATOR

University of British Columbia

Alison Phinney, PhD

Role: PRINCIPAL_INVESTIGATOR

University of British Columbia

Karim Khan, PhD

Role: PRINCIPAL_INVESTIGATOR

University of British Columbia

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre for Hip Health and Mobility

Vancouver, British Columbia, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TE1-138295

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

STP-MOTM

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.